Xtant Medical Holdings
XTNT on NYSEAmerican. Market value $46m.
Should I look at this?
We have not checked this company yet
This is not advice.
Who owns it
None of the long-term investors we follow own it. 32 funds in all.
Largest holders overall
- Nantahala Capital Management$58mAdded
- AWM Investment Company$3m
- Vanguard Capital Management$848,148
- Renaissance Technologies$393,685Cut
- Geode Capital Management$217,773Cut
- Crescent Grove Advisors$173,462
- Nano CAP New Millennium Growth Fund L P$168,400Added
- Vanguard Fiduciary Trust$108,613
- Citadel Advisors$80,566Added
- Acadian Asset Management$73,000
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
2 investors own more than 5%.
- at least 49.1%0.0 pts(filed with 3 related holders)Since 1 August 2025
What they said
Item 4 is amended by the addition of the following: On August 1, 2025, the Board of Directors (the "Board") of the Issuer elected Abhinav (Abi) Jain, an Analyst at NCM, to the Board. Mr. Jain was appointed to serve as a member of the Compensation Committee and Nominating and…
Read the filing - LYTTON LAURENCE WPassive investorat least 5.5%−1.3 pts(filed with 1 related holder)Since 31 December 2025
- ORBIMED ADVISORS LLCPassive investorSold down below 5%Since 10 April 2025
What they said
The Reporting Persons from time to time intend to review their investment in the Issuer on the basis of various factors, including the Issuer's business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in…
Read the filing
| Holder | Stake | Since | |
|---|---|---|---|
at least 49.1%0.0 pts (filed with 3 related holders) | 1 August 2025 | What they saidItem 4 is amended by the addition of the following: On August 1, 2025, the Board of Directors (the "Board") of the Issuer elected Abhinav (Abi) Jain, an Analyst at NCM, to the Board. Mr. Jain was appointed to serve as a member of the Compensation Committee and Nominating and… Read the filing | |
LYTTON LAURENCE W Passive investor | at least 5.5%−1.3 pts (filed with 1 related holder) | 31 December 2025 | |
ORBIMED ADVISORS LLC Passive investor | Sold down below 5% | 10 April 2025 | What they saidThe Reporting Persons from time to time intend to review their investment in the Issuer on the basis of various factors, including the Issuer's business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in… Read the filing |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
No insider bought or sold on the open market in the last 12 months.
From Form 4 filings: insiders must report trades in their own company's shares within two days.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.